Ken Griffin Mainz Biomed N.V. Put Options Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MYNZ
# of Institutions
13Shares Held
147KCall Options Held
0Put Options Held
0-
Northern Trust Corp Chicago, IL29.9KShares$11,9730.0% of portfolio
-
Xtx Topco LTD London, X028.8KShares$11,5100.0% of portfolio
-
Vontobel Holding Ltd.25KShares$10,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.2KShares$6,0750.0% of portfolio
-
Greenwich Investment Management, Inc. Stamford, CT12KShares$4,7930.01% of portfolio
About MAINZ BIOMED N.V.
- Ticker MYNZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 14,483,000
- Market Cap $5.79M
- Description
- Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...